ARQT FY 2020 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$455,000

Operating Income

-$137M

Net Income

-$136M

EPS (Diluted)

$-3.80

Cash Flow

Operating Cash Flow

-$113M

Free Cash Flow

-$113M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$298M

Total Liabilities

$28M

Stockholders' Equity

$271M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$455,000	-$195,000	-133.3%
Operating Income	-$137M	-$43M	-216.8%
Net Income	-$136M	-$42M	-223.1%